In contrast, tau and FDG pathological changes have been reported as strong biomarkers that are associated with cognitive decline especially in the later stage due to atrophy (Koss et al., 2016; Huber et al., 2018; Iida et al., 2021). Here, MAPT is linked to Mental deterioration.